 |
|
| Systematic (IUPAC) name | |
|---|---|
| (2R,8S,14S,15S)-14-acetyl-14-hydroxy-2,15-dimethyl-8-(trifluoromethyl)tetracyclo[8.7.0.0 2,7.011,15]heptadec-6-en-5-one | |
| Identifiers | |
| CAS number | 987-18-8 |
| ATC code | N02CB01 |
| PubChem | 71881 |
| Chemical data | |
| Formula | C 22H29F3O3 |
| Mol. mass | 398.459 g/mol |
| Synonyms |
(6S,10R,13S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-6-(trifluoromethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1
H-cyclopenta[a]phenanthren-3-one 17-Acetyloxy-6α-(trifluoromethyl)preg-4-ene-3,20-dione |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Flumedroxone is a corticosteroid derivative used to treat migraines. In one study, the benefit was largely limited to women with headache associated with premenstrual syndrome.[1]
|
|||||||||||||||||||||||||||
|
|
Wikis
Search